[
  {
    "title": "凯赛生物(688065.SH)：完成回购、已实际回购113.3035万股",
    "href": "http://stock.jrj.com.cn/2022/11/30173437178631.shtml",
    "datetime": "2022-11-30 17:34:09",
    "code": "688065"
  },
  {
    "title": "凯赛生物股东迪维投资减持1万股 套现79.7万 2022年前三季度公司净利4.86亿",
    "href": "http://stock.jrj.com.cn/2022/11/16211137144959.shtml",
    "datetime": "2022-11-16 21:11:29",
    "code": "688065"
  },
  {
    "title": "凯赛生物(688065.SH)：减持期届满 仅迪维投资累计减持1万股",
    "href": "http://stock.jrj.com.cn/2022/11/16175037144224.shtml",
    "datetime": "2022-11-16 17:50:40",
    "code": "688065"
  },
  {
    "title": "凯赛生物(688065.SH)：截至10月底已累计回购113.30万股",
    "href": "http://stock.jrj.com.cn/2022/10/31155337099805.shtml",
    "datetime": "2022-10-31 15:53:32",
    "code": "688065"
  },
  {
    "title": "凯赛生物(688065.SH)第三季度净利润1.50亿元、同比下降8.47%",
    "href": "http://stock.jrj.com.cn/2022/10/27164637089915.shtml",
    "datetime": "2022-10-27 16:46:45",
    "code": "688065"
  },
  {
    "title": "凯赛生物(688065.SH)：拟使用不超15亿元暂时闲置募集资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2022/10/10205337045243.shtml",
    "datetime": "2022-10-10 20:53:03",
    "code": "688065"
  },
  {
    "title": "凯赛生物(688065.SH)：截至9月底已累计回购113.3万股",
    "href": "http://stock.jrj.com.cn/2022/10/09165537041777.shtml",
    "datetime": "2022-10-09 16:55:06",
    "code": "688065"
  },
  {
    "title": "凯赛生物(688065.SH)：减持期过半 4名股东累计减持1万股",
    "href": "http://stock.jrj.com.cn/2022/10/09165137041781.shtml",
    "datetime": "2022-10-09 16:51:26",
    "code": "688065"
  },
  {
    "title": "凯赛生物(688065.SH)：2500.0919万股限售股将解禁",
    "href": "http://stock.jrj.com.cn/2022/09/19171737005182.shtml",
    "datetime": "2022-09-19 17:17:06",
    "code": "688065"
  },
  {
    "title": "凯赛生物(688065.SH)：10.78万股归属股票将于9月20日上市流通",
    "href": "http://stock.jrj.com.cn/2022/09/16180237001063.shtml",
    "datetime": "2022-09-16 18:02:44",
    "code": "688065"
  },
  {
    "title": "凯赛生物(688065.SH)截至8月底已累计回购95.7035万股",
    "href": "http://stock.jrj.com.cn/2022/09/01162336963153.shtml",
    "datetime": "2022-09-01 16:23:56",
    "code": "688065"
  },
  {
    "title": "凯赛生物披露2022年半年报，实现营收12.89亿元",
    "href": "http://stock.jrj.com.cn/2022/08/12110336894348.shtml",
    "datetime": "2022-08-12 11:03:54",
    "code": "688065"
  },
  {
    "title": "凯赛生物2022年上半年净利3.36亿同比增长7.71% 利息收入增加",
    "href": "http://stock.jrj.com.cn/2022/08/11223236892368.shtml",
    "datetime": "2022-08-11 22:32:25",
    "code": "688065"
  },
  {
    "title": "凯赛生物(688065.SH)：上半年净利润增7.71%至3.36亿元",
    "href": "http://stock.jrj.com.cn/2022/08/11175836891420.shtml",
    "datetime": "2022-08-11 17:58:02",
    "code": "688065"
  },
  {
    "title": "凯赛生物(688065.SH)：116.6708万股战略配售限售股将解禁",
    "href": "http://stock.jrj.com.cn/2022/08/03165336867067.shtml",
    "datetime": "2022-08-03 16:53:05",
    "code": "688065"
  },
  {
    "title": "凯赛生物(688065)：独立董事公开征集委托投票权",
    "href": "http://stock.jrj.com.cn/2022/08/03091436865681.shtml",
    "datetime": "2022-08-03 09:14:35",
    "code": "688065"
  },
  {
    "title": "凯赛生物(688065)：以集中竞价交易方式回购公司股份",
    "href": "http://stock.jrj.com.cn/2022/08/02092836861908.shtml",
    "datetime": "2022-08-02 09:28:36",
    "code": "688065"
  },
  {
    "title": "凯赛生物(688065)：股东集中竞价减持股份计划",
    "href": "http://stock.jrj.com.cn/2022/07/27093336846006.shtml",
    "datetime": "2022-07-27 09:33:06",
    "code": "688065"
  },
  {
    "title": "凯赛生物：股东拟合计减持公司不超1%股份",
    "href": "http://stock.jrj.com.cn/2022/07/26190836844528.shtml",
    "datetime": "2022-07-26 19:08:07",
    "code": "688065"
  },
  {
    "title": "凯赛生物(688065.SH)：迪维投资及一致行动人拟合计减持不超583.1703万股",
    "href": "http://stock.jrj.com.cn/2022/07/26185336844518.shtml",
    "datetime": "2022-07-26 18:53:10",
    "code": "688065"
  },
  {
    "title": "凯赛生物(688065.SH)拟推220万股的2022年限制性股票激励计划",
    "href": "http://stock.jrj.com.cn/2022/07/18182836822065.shtml",
    "datetime": "2022-07-18 18:28:05",
    "code": "688065"
  },
  {
    "title": "凯赛生物(688065.SH)：核心技术人员陈万钟退休离任",
    "href": "http://stock.jrj.com.cn/2022/07/06175636787717.shtml",
    "datetime": "2022-07-06 17:56:45",
    "code": "688065"
  },
  {
    "title": "凯赛生物(688065.SH)：截至6月底已累计回购46.09万股",
    "href": "http://stock.jrj.com.cn/2022/06/30154536771440.shtml",
    "datetime": "2022-06-30 15:45:15",
    "code": "688065"
  },
  {
    "title": "凯赛生物(688065.SH)：首次回购4.37万股 涉资428.01万元",
    "href": "http://stock.jrj.com.cn/2022/06/02171236700858.shtml",
    "datetime": "2022-06-02 17:12:57",
    "code": "688065"
  },
  {
    "title": "凯赛生物2022年第一季度净利1.75亿同比增长24% 长链二元酸销售收入增加",
    "href": "http://stock.jrj.com.cn/2022/05/04113236554321.shtml",
    "datetime": "2022-05-04 11:32:49",
    "code": "688065"
  },
  {
    "title": "凯赛生物：一季度营收利润双增 产能扩张未来可期",
    "href": "http://stock.jrj.com.cn/2022/04/27112436482673.shtml",
    "datetime": "2022-04-27 11:24:43",
    "code": "688065"
  },
  {
    "title": "凯赛生物披露2022年一季报 实现营收6.61亿元",
    "href": "http://stock.jrj.com.cn/2022/04/27105136482247.shtml",
    "datetime": "2022-04-27 10:51:00",
    "code": "688065"
  },
  {
    "title": "凯赛生物(688065.SH)：一季度净利润增23.54%至1.75亿元",
    "href": "http://stock.jrj.com.cn/2022/04/26174236476875.shtml",
    "datetime": "2022-04-26 17:42:56",
    "code": "688065"
  },
  {
    "title": "凯赛生物(688065.SH)：减持期届满 迪维投资累计减持0.91%股份",
    "href": "http://stock.jrj.com.cn/2022/04/14205236337747.shtml",
    "datetime": "2022-04-14 20:52:33",
    "code": "688065"
  },
  {
    "title": "凯赛生物业绩说明会如期举办 产品推广与秸秆进展等一一解答",
    "href": "http://stock.jrj.com.cn/2022/04/13132736322852.shtml",
    "datetime": "2022-04-13 13:27:34",
    "code": "688065"
  },
  {
    "title": "凯赛生物(688065.SH)：尚未进行回购交易",
    "href": "http://stock.jrj.com.cn/2022/04/07160436267989.shtml",
    "datetime": "2022-04-07 16:04:52",
    "code": "688065"
  },
  {
    "title": "凯赛生物：2021年净利润增长超30% 生物基聚酰胺产业化实现",
    "href": "http://stock.jrj.com.cn/2022/04/06231036265226.shtml",
    "datetime": "2022-04-06 23:10:28",
    "code": "688065"
  },
  {
    "title": "凯赛生物2021年净利6.08亿同比增长32.82% 董事长刘修才薪酬437.3万",
    "href": "http://stock.jrj.com.cn/2022/04/06225136265077.shtml",
    "datetime": "2022-04-06 22:51:54",
    "code": "688065"
  },
  {
    "title": "凯赛生物(688065.SH)：2021年净利增32.82%至6.08亿元 拟10派4.5元",
    "href": "http://stock.jrj.com.cn/2022/04/06193336264085.shtml",
    "datetime": "2022-04-06 19:33:00",
    "code": "688065"
  },
  {
    "title": "A股异动 | 凯赛生物(688065.SH)涨10% 拟回购0.8亿-1.5亿元股份",
    "href": "http://stock.jrj.com.cn/2022/03/30100736183848.shtml",
    "datetime": "2022-03-30 10:07:45",
    "code": "688065"
  },
  {
    "title": "凯赛生物(688065.SH)：拟以0.8亿-1.5亿元回购公司股份",
    "href": "http://stock.jrj.com.cn/2022/03/29201836156060.shtml",
    "datetime": "2022-03-29 20:18:21",
    "code": "688065"
  },
  {
    "title": "凯赛生物2021年净利6.04亿同比增长31.89% 收入增长以及利息收入增加",
    "href": "http://stock.jrj.com.cn/2022/02/24201334453242.shtml",
    "datetime": "2022-02-24 20:13:16",
    "code": "688065"
  },
  {
    "title": "凯赛生物变更募资用途上马新项目遭问询：回复函先重点说明风险",
    "href": "http://stock.jrj.com.cn/2022/01/21101234181346.shtml",
    "datetime": "2022-01-21 10:12:03",
    "code": "688065"
  },
  {
    "title": "凯赛生物股东华宇瑞泰减持406.1万股 套现6.68亿 2021年第三季度公司净利1.64亿",
    "href": "http://stock.jrj.com.cn/2022/01/18191234170828.shtml",
    "datetime": "2022-01-18 19:12:03",
    "code": "688065"
  },
  {
    "title": "凯赛生物(688065.SH)：减持期届满 华宇瑞泰已减持0.97%股份",
    "href": "http://stock.jrj.com.cn/2022/01/18164434169908.shtml",
    "datetime": "2022-01-18 16:44:00",
    "code": "688065"
  },
  {
    "title": "凯赛生物聘任杨晨为公司副总裁 2021年第三季度公司净利1.64亿",
    "href": "http://stock.jrj.com.cn/2022/01/17205034166195.shtml",
    "datetime": "2022-01-17 20:50:57",
    "code": "688065"
  },
  {
    "title": "凯赛生物部分募投项目变更 上交所两问上市公司利益",
    "href": "http://stock.jrj.com.cn/2022/01/12161134150065.shtml",
    "datetime": "2022-01-12 16:11:00",
    "code": "688065"
  },
  {
    "title": "分析该项目科创属性？凯赛生物收上交所问询函",
    "href": "http://stock.jrj.com.cn/2022/01/12113534149208.shtml",
    "datetime": "2022-01-12 11:35:15",
    "code": "688065"
  },
  {
    "title": "凯赛生物钱多了胃口变大：IPO募投项目一变再变拟上马总投资138亿项目 上交所16问",
    "href": "http://stock.jrj.com.cn/2022/01/12112234149181.shtml",
    "datetime": "2022-01-12 11:22:51",
    "code": "688065"
  },
  {
    "title": "凯赛生物(688065.SH)：拟变更部分募投项目 用于“年产50万吨生物基戊二胺及90万吨生物基聚酰胺项目”",
    "href": "http://stock.jrj.com.cn/2022/01/11155334146095.shtml",
    "datetime": "2022-01-11 15:53:21",
    "code": "688065"
  },
  {
    "title": "凯赛生物(688065.SH)：拟使用1.7亿元超募资金永久补充流动资金",
    "href": "http://stock.jrj.com.cn/2021/12/06215433975689.shtml",
    "datetime": "2021-12-06 21:54:41",
    "code": "688065"
  },
  {
    "title": "凯赛生物(688065.SH)：减持数过半 华宇瑞泰累计减持220.939万股",
    "href": "http://stock.jrj.com.cn/2021/12/01164833950161.shtml",
    "datetime": "2021-12-01 16:48:54",
    "code": "688065"
  },
  {
    "title": "凯赛生物(688065.SH)：山西科创城投以大宗交易减持1.9991%的股份",
    "href": "http://stock.jrj.com.cn/2021/11/26172233924099.shtml",
    "datetime": "2021-11-26 17:22:51",
    "code": "688065"
  },
  {
    "title": "凯赛生物(688065.SH)：迪维投资、延福新材已减持231.39万股 减持数过半",
    "href": "http://stock.jrj.com.cn/2021/11/22170133904266.shtml",
    "datetime": "2021-11-22 17:01:51",
    "code": "688065"
  },
  {
    "title": "凯赛生物：前三季度净利润4.90亿元，同比增长52.50%",
    "href": "http://stock.jrj.com.cn/2021/10/30111333782611.shtml",
    "datetime": "2021-10-30 11:13:35",
    "code": "688065"
  },
  {
    "title": "凯赛生物三季报：营收16.33亿元同比增逾四成 生物基聚酰胺投产并形成销售收入",
    "href": "http://stock.jrj.com.cn/2021/10/29174133778495.shtml",
    "datetime": "2021-10-29 17:41:11",
    "code": "688065"
  },
  {
    "title": "凯赛生物(688065.SH)第三季度净利润1.64亿元 同比增长42.41%",
    "href": "http://stock.jrj.com.cn/2021/10/28203233771991.shtml",
    "datetime": "2021-10-28 20:32:43",
    "code": "688065"
  },
  {
    "title": "凯赛生物(688065.SH)：向54名激励对象授予10万股限制性股票",
    "href": "http://stock.jrj.com.cn/2021/10/08201433659221.shtml",
    "datetime": "2021-10-08 20:14:45",
    "code": "688065"
  },
  {
    "title": "凯赛生物(688065.SH)：拟使用不超25亿元闲置募集资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2021/10/08201333659220.shtml",
    "datetime": "2021-10-08 20:13:42",
    "code": "688065"
  },
  {
    "title": "凯赛生物股东华宇瑞泰拟减持不超416.68万股公司股份 上半年公司净利3.26亿",
    "href": "http://stock.jrj.com.cn/2021/09/17202033453189.shtml",
    "datetime": "2021-09-17 20:20:34",
    "code": "688065"
  },
  {
    "title": "凯赛生物(688065.SH)：持股4.75%的华宇瑞泰拟减持不超1%的股份",
    "href": "http://stock.jrj.com.cn/2021/09/17171133452121.shtml",
    "datetime": "2021-09-17 17:11:23",
    "code": "688065"
  },
  {
    "title": "凯赛生物2名股东拟合计减持不超416.68万股公司股份 上半年公司净利3.26亿",
    "href": "http://stock.jrj.com.cn/2021/09/14194733435182.shtml",
    "datetime": "2021-09-14 19:47:11",
    "code": "688065"
  },
  {
    "title": "凯赛生物(688065.SH)：迪维投资、延福新材拟减持不超1%的股份",
    "href": "http://stock.jrj.com.cn/2021/09/14174833434677.shtml",
    "datetime": "2021-09-14 17:48:18",
    "code": "688065"
  },
  {
    "title": "华鲁恒升凯赛生物均跌4% 基金大佬兴全谢治宇调仓？",
    "href": "http://stock.jrj.com.cn/2021/09/10172933415934.shtml",
    "datetime": "2021-09-10 17:29:00",
    "code": "688065"
  },
  {
    "title": "凯赛生物(688065.SH)：华宇瑞泰减持8万股 持股比例减至4.9978%",
    "href": "http://stock.jrj.com.cn/2021/09/03184933381360.shtml",
    "datetime": "2021-09-03 18:49:54",
    "code": "688065"
  },
  {
    "title": "凯赛生物、康熙诺、石头科技能多股涨超6%，科创创业ETF(588360)涨超2%",
    "href": "http://stock.jrj.com.cn/2021/08/23105733301508.shtml",
    "datetime": "2021-08-23 10:57:35",
    "code": "688065"
  },
  {
    "title": "凯赛生物拉升涨超8%创逾1年新高 Q2业绩同比环比均大幅上涨",
    "href": "http://stock.jrj.com.cn/2021/08/23101533301172.shtml",
    "datetime": "2021-08-23 10:15:02",
    "code": "688065"
  },
  {
    "title": "凯赛生物半年报：需求稳步复苏 归母净利润同比增长58.12%",
    "href": "http://stock.jrj.com.cn/2021/08/19083033278122.shtml",
    "datetime": "2021-08-19 08:30:29",
    "code": "688065"
  },
  {
    "title": "凯赛生物2021年半年度净利3.26亿元 同比净利增加58.12%",
    "href": "http://stock.jrj.com.cn/2021/08/18180433274833.shtml",
    "datetime": "2021-08-18 18:04:37",
    "code": "688065"
  },
  {
    "title": "凯赛生物(688065.SH)半年度净利润3.26亿元 同比增长58.12%",
    "href": "http://stock.jrj.com.cn/2021/08/18171133274354.shtml",
    "datetime": "2021-08-18 17:11:38",
    "code": "688065"
  },
  {
    "title": "凯赛生物(688065.SH)：1.29亿股限售股将于8月12日上市流通",
    "href": "http://stock.jrj.com.cn/2021/08/03165033195371.shtml",
    "datetime": "2021-08-03 16:50:27",
    "code": "688065"
  },
  {
    "title": "凯赛生物(688065.SH)2020年度权益分派10派8元 股权登记日为7月26日",
    "href": "http://stock.jrj.com.cn/2021/07/20170033124736.shtml",
    "datetime": "2021-07-20 17:00:13",
    "code": "688065"
  },
  {
    "title": "A股异动 | 凯赛生物(688065.SH)涨超7%创8个月新高 生物基尼龙即将投产",
    "href": "http://stock.jrj.com.cn/2021/06/23144132982728.shtml",
    "datetime": "2021-06-23 14:41:26",
    "code": "688065"
  },
  {
    "title": "凯赛生物：公司乌苏项目正在有序正常进行中",
    "href": "http://stock.jrj.com.cn/2021/06/21095132967685.shtml",
    "datetime": "2021-06-21 09:51:50",
    "code": "688065"
  },
  {
    "title": "凯赛生物：目前生物基可降解材料课题在实验室研究有了一定进展",
    "href": "http://stock.jrj.com.cn/2021/06/21095132967684.shtml",
    "datetime": "2021-06-21 09:51:22",
    "code": "688065"
  },
  {
    "title": "凯赛生物(688065.SH)：核心技术人员高伯爵离职",
    "href": "http://stock.jrj.com.cn/2021/06/11190532912790.shtml",
    "datetime": "2021-06-11 19:05:49",
    "code": "688065"
  },
  {
    "title": "凯赛生物聘任左骏为副总裁 未持有公司股票",
    "href": "http://stock.jrj.com.cn/2021/06/07193632888389.shtml",
    "datetime": "2021-06-07 19:36:43",
    "code": "688065"
  },
  {
    "title": "长阳科技等5只个股调出科创50指数名单 凯赛生物、康希诺、圣湘生物等5只调入",
    "href": "http://stock.jrj.com.cn/2021/06/07093232885624.shtml",
    "datetime": "2021-06-07 09:32:24",
    "code": "688065"
  },
  {
    "title": "凯赛生物：公司将在上海和山西增加合成生物学全产业链高通量研发设施",
    "href": "http://stock.jrj.com.cn/2021/05/12145332741870.shtml",
    "datetime": "2021-05-12 14:53:42",
    "code": "688065"
  },
  {
    "title": "凯赛生物(688065.SH)：一季度净利1.41亿元 同比增长19.45%",
    "href": "http://stock.jrj.com.cn/2021/04/26155832454242.shtml",
    "datetime": "2021-04-26 15:58:49",
    "code": "688065"
  },
  {
    "title": "凯赛生物：目前山西项目进展顺利",
    "href": "http://stock.jrj.com.cn/2021/04/12092132355724.shtml",
    "datetime": "2021-04-12 09:21:37",
    "code": "688065"
  },
  {
    "title": "凯赛生物：改性聚酯纤维作为公司的一个储备技术和产品 目前尚未进行生产",
    "href": "http://stock.jrj.com.cn/2021/04/12091632355693.shtml",
    "datetime": "2021-04-12 09:16:41",
    "code": "688065"
  },
  {
    "title": "凯赛生物：公司已经注册了主要应用于纺织领域的商标“泰纶”",
    "href": "http://stock.jrj.com.cn/2021/04/12091632355690.shtml",
    "datetime": "2021-04-12 09:16:31",
    "code": "688065"
  },
  {
    "title": "凯赛生物：聚酰胺对应的营业收入为公司长链二元酸产品在聚酰胺行业中实现的收入",
    "href": "http://stock.jrj.com.cn/2021/04/12091532355692.shtml",
    "datetime": "2021-04-12 09:15:30",
    "code": "688065"
  },
  {
    "title": "凯赛生物2020年净利下滑4.43% 董事长刘修才薪酬437.16万",
    "href": "http://stock.jrj.com.cn/2021/03/29223132243711.shtml",
    "datetime": "2021-03-29 22:31:21",
    "code": "688065"
  },
  {
    "title": "“生物制造开拓者”凯赛生物年报首秀：三大战略巩固领先优势",
    "href": "http://stock.jrj.com.cn/2021/03/29201732243204.shtml",
    "datetime": "2021-03-29 20:17:48",
    "code": "688065"
  },
  {
    "title": "凯赛生物(688065.SH)2020年度净利润降4.43%至4.58亿元 拟10派8元",
    "href": "http://stock.jrj.com.cn/2021/03/29184132242555.shtml",
    "datetime": "2021-03-29 18:41:33",
    "code": "688065"
  },
  {
    "title": "凯赛生物股东天津四通质押384.77万股 用于为第三方公司提供担保",
    "href": "http://stock.jrj.com.cn/2021/03/12211032122983.shtml",
    "datetime": "2021-03-12 21:10:58",
    "code": "688065"
  },
  {
    "title": "凯赛生物(688065.SH)：持股5%以上的天津四通质押384.7728万股",
    "href": "http://stock.jrj.com.cn/2021/03/12183432121473.shtml",
    "datetime": "2021-03-12 18:34:17",
    "code": "688065"
  },
  {
    "title": "凯赛生物：公司基于生物基戊二胺生产一系列的聚酰胺产品 在下游受到广泛认可",
    "href": "http://stock.jrj.com.cn/2021/03/05181232079444.shtml",
    "datetime": "2021-03-05 18:12:06",
    "code": "688065"
  },
  {
    "title": "凯赛生物2020年度净利4.47亿下滑6.69% 在建项目进度有所延迟",
    "href": "http://stock.jrj.com.cn/2021/02/24192132020141.shtml",
    "datetime": "2021-02-24 19:21:36",
    "code": "688065"
  },
  {
    "title": "凯赛生物：公司和中国科学院天津工业生物技术研究所牵头建设的国家合成生物技术创新中心目前没有业务合作",
    "href": "http://stock.jrj.com.cn/2021/02/08092631868145.shtml",
    "datetime": "2021-02-08 09:26:08",
    "code": "688065"
  },
  {
    "title": "凯赛生物：乌苏10万吨生物基聚酰胺生产线正在加紧调试",
    "href": "http://stock.jrj.com.cn/2021/02/08084931867987.shtml",
    "datetime": "2021-02-08 08:49:33",
    "code": "688065"
  },
  {
    "title": "凯赛生物：乌苏10万吨生物基聚酰胺生产线预计今年中期具备量产条件",
    "href": "http://stock.jrj.com.cn/2021/02/08083631867923.shtml",
    "datetime": "2021-02-08 08:36:52",
    "code": "688065"
  },
  {
    "title": "凯赛生物：公司生物基聚酰胺56产品相比聚酰胺66 在吸湿性、阻燃性、染色性等方面性能有所提升",
    "href": "http://stock.jrj.com.cn/2021/02/08083531867917.shtml",
    "datetime": "2021-02-08 08:35:36",
    "code": "688065"
  },
  {
    "title": "凯赛生物：乌苏10万吨生物基聚酰胺生产线正在加紧调试",
    "href": "http://stock.jrj.com.cn/2021/02/01100331827742.shtml",
    "datetime": "2021-02-01 10:03:34",
    "code": "688065"
  },
  {
    "title": "凯赛生物：公司的生物基聚酰胺为不同品种和牌号的系列产品",
    "href": "http://stock.jrj.com.cn/2021/02/01100331827749.shtml",
    "datetime": "2021-02-01 10:03:14",
    "code": "688065"
  },
  {
    "title": "凯赛生物：公司应用在面料上的产品是生物基聚酰胺 而恒力、恒逸、桐昆的产品主要是聚酯",
    "href": "http://stock.jrj.com.cn/2021/02/01100231827743.shtml",
    "datetime": "2021-02-01 10:02:06",
    "code": "688065"
  },
  {
    "title": "凯赛生物：公司“ECOPENT”系列产品可适用于汽车领域多种用途",
    "href": "http://stock.jrj.com.cn/2021/02/01093731827480.shtml",
    "datetime": "2021-02-01 09:37:55",
    "code": "688065"
  },
  {
    "title": "凯赛生物：公司目前不生产己二胺",
    "href": "http://stock.jrj.com.cn/2021/01/05112131633146.shtml",
    "datetime": "2021-01-05 11:21:45",
    "code": "688065"
  },
  {
    "title": "凯赛生物：公司的一款长链二元酸产品应用于索马鲁肽的生产",
    "href": "http://stock.jrj.com.cn/2020/12/21094531534028.shtml",
    "datetime": "2020-12-21 09:45:07",
    "code": "688065"
  },
  {
    "title": "“富达高瓴”国际大咖机构调研纷至沓来 凯赛生物布局多种生物基新材料",
    "href": "http://stock.jrj.com.cn/2020/12/11083131462532.shtml",
    "datetime": "2020-12-11 08:31:16",
    "code": "688065"
  },
  {
    "title": "凯赛生物公告IPO募投项目变更 生物法癸二酸项目产能建设维持不变",
    "href": "http://stock.jrj.com.cn/2020/12/01181831386077.shtml",
    "datetime": "2020-12-01 18:18:25",
    "code": "688065"
  },
  {
    "title": "凯赛生物：长链二元酸没有满产的原因主要是客户需要一定时间对新的生产线进行验证 以及疫情影响",
    "href": "http://stock.jrj.com.cn/2020/11/30094431373810.shtml",
    "datetime": "2020-11-30 09:44:04",
    "code": "688065"
  },
  {
    "title": "凯赛生物：目前公司已经通过客户试用的领域包括服装、轮胎帘子布、食品膜、扎带、隔热条等",
    "href": "http://stock.jrj.com.cn/2020/11/30093931373742.shtml",
    "datetime": "2020-11-30 09:39:03",
    "code": "688065"
  },
  {
    "title": "凯赛生物：公司的生物基聚酰胺产品中有专门针对这两个领域应用的产品系列",
    "href": "http://stock.jrj.com.cn/2020/11/12122431266451.shtml",
    "datetime": "2020-11-12 12:24:06",
    "code": "688065"
  },
  {
    "title": "凯赛生物：在部分项目研发过程中 采取与大学和科研院所展开合作研发的方式",
    "href": "http://stock.jrj.com.cn/2020/11/11084631257146.shtml",
    "datetime": "2020-11-11 08:46:03",
    "code": "688065"
  },
  {
    "title": "凯赛生物：PA56和PA66分别具有不同的材料属性",
    "href": "http://stock.jrj.com.cn/2020/11/10093531248764.shtml",
    "datetime": "2020-11-10 09:35:47",
    "code": "688065"
  },
  {
    "title": "凯赛生物：公司有效控制戊二胺的生产成本，使得产业化成为可能。",
    "href": "http://stock.jrj.com.cn/2020/11/10093331248738.shtml",
    "datetime": "2020-11-10 09:33:07",
    "code": "688065"
  },
  {
    "title": "凯赛生物：探索生物制造边界 引领行业发展趋势",
    "href": "http://stock.jrj.com.cn/2020/10/27214031144610.shtml",
    "datetime": "2020-10-27 21:40:45",
    "code": "688065"
  },
  {
    "title": "凯赛生物：2020年前三季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2020/10/27001031137017.shtml",
    "datetime": "2020-10-27 00:10:17",
    "code": "688065"
  },
  {
    "title": "凯赛生物2020年前三季度净利3.21亿减少13.77% 所得税费用减少",
    "href": "http://stock.jrj.com.cn/2020/10/26230831136847.shtml",
    "datetime": "2020-10-26 23:08:17",
    "code": "688065"
  },
  {
    "title": "凯赛生物携手山西省 探索战略领域“中国主导”模式",
    "href": "http://stock.jrj.com.cn/2020/10/11203931019850.shtml",
    "datetime": "2020-10-11 20:39:10",
    "code": "688065"
  },
  {
    "title": "凯赛生物：拟投资生物法长链二元酸等产业化项目",
    "href": "http://stock.jrj.com.cn/2020/10/11144231018949.shtml",
    "datetime": "2020-10-11 14:42:42",
    "code": "688065"
  },
  {
    "title": "凯赛生物：第一届董事会第十一次会议决议公告",
    "href": "http://stock.jrj.com.cn/2020/10/10001031013078.shtml",
    "datetime": "2020-10-10 00:10:08",
    "code": "688065"
  },
  {
    "title": "凯赛生物：召开2020年第二次临时股东大会的通知",
    "href": "http://stock.jrj.com.cn/2020/10/10001031013079.shtml",
    "datetime": "2020-10-10 00:10:08",
    "code": "688065"
  },
  {
    "title": "凯赛生物(688065.SH)：拟使用募集资金1.1亿元置换先期投入",
    "href": "http://stock.jrj.com.cn/2020/10/09190631011812.shtml",
    "datetime": "2020-10-09 19:06:22",
    "code": "688065"
  },
  {
    "title": "凯赛生物：公司曾参与国家高科技研究发展计等多个国家级研发项目",
    "href": "http://stock.jrj.com.cn/2020/09/16085630760008.shtml",
    "datetime": "2020-09-16 08:56:40",
    "code": "688065"
  },
  {
    "title": "凯赛生物(688065.SH)：实控人及控股股东等人延长股份锁定期",
    "href": "http://stock.jrj.com.cn/2020/09/15185930756626.shtml",
    "datetime": "2020-09-15 18:59:52",
    "code": "688065"
  },
  {
    "title": "科创板股票凯赛生物破发 上市仅四个交易日",
    "href": "http://stock.jrj.com.cn/2020/08/17101930515821.shtml",
    "datetime": "2020-08-17 10:19:45",
    "code": "688065"
  },
  {
    "title": "上市次日大跌逾10% 科创板股票凯赛生物险“破发”",
    "href": "http://stock.jrj.com.cn/2020/08/13143430491401.shtml",
    "datetime": "2020-08-13 14:34:35",
    "code": "688065"
  },
  {
    "title": "凯赛生物今日上市 发行价格133.45元/股",
    "href": "http://stock.jrj.com.cn/ipo/2020/08/12080930479789.shtml",
    "datetime": "2020-08-12 08:09:09",
    "code": "688065"
  },
  {
    "title": "凯赛生物中签号出炉 中签号码共有22207个",
    "href": "http://stock.jrj.com.cn/ipo/2020/08/05082130429638.shtml",
    "datetime": "2020-08-05 08:21:25",
    "code": "688065"
  },
  {
    "title": "【兑奖啦】奥海科技、凯赛生物网上申购中签号出炉",
    "href": "http://stock.jrj.com.cn/ipo/2020/08/04215330426373.shtml",
    "datetime": "2020-08-04 21:53:14",
    "code": "688065"
  },
  {
    "title": "【兑奖啦】凯赛生物网上申购中签号出炉",
    "href": "http://stock.jrj.com.cn/ipo/2020/08/04191530425451.shtml",
    "datetime": "2020-08-04 19:15:11",
    "code": "688065"
  },
  {
    "title": "科创板凯赛生物今日申购！发行价高达133.45元/股 或也能成为医药大肉签",
    "href": "http://stock.jrj.com.cn/kcb/2020/08/03111330411720.shtml",
    "datetime": "2020-08-03 11:13:17",
    "code": "688065"
  },
  {
    "title": "科创板新股凯赛生物8月3日申购宝典",
    "href": "http://stock.jrj.com.cn/kcb/2020/07/31143730393248.shtml",
    "datetime": "2020-07-31 14:37:15",
    "code": "688065"
  },
  {
    "title": "“硬核”科技股凯赛生物IPO在即 戊二胺产品技术有望突破行业瓶颈 | 产业新股",
    "href": "http://stock.jrj.com.cn/2020/06/30200130099848.shtml",
    "datetime": "2020-06-30 20:01:29",
    "code": "688065"
  },
  {
    "title": "前沿生物、凯赛生物6月5日科创板上会",
    "href": "http://stock.jrj.com.cn/2020/05/28090429785181.shtml",
    "datetime": "2020-05-28 09:04:00",
    "code": "688065"
  },
  {
    "title": "凯赛生物冲刺科创板拟募资47亿元",
    "href": "http://stock.jrj.com.cn/kcb/2019/12/16044828535343.shtml",
    "datetime": "2019-12-16 04:48:06",
    "code": "688065"
  },
  {
    "title": "凯赛生物拟募集资金46.99亿元提升产能",
    "href": "http://stock.jrj.com.cn/kcb/2019/12/12042728521987.shtml",
    "datetime": "2019-12-12 04:27:54",
    "code": "688065"
  },
  {
    "title": "凯赛生物完成科创板上市辅导 主营生物基材料替代石化产品",
    "href": "http://stock.jrj.com.cn/2019/11/27222628460107.shtml",
    "datetime": "2019-11-27 22:26:48",
    "code": "688065"
  },
  {
    "title": "凯赛生物IPO辅导期间新增5位股东 招银国际成前十大股东",
    "href": "http://stock.jrj.com.cn/ipo/2019/10/15095128248157.shtml",
    "datetime": "2019-10-15 09:51:02",
    "code": "688065"
  },
  {
    "title": "生物制造产业开拓者迈出IPO第一步：凯赛生物接受上市辅导",
    "href": "http://stock.jrj.com.cn/ipo/2019/09/25101928176728.shtml",
    "datetime": "2019-09-25 10:19:32",
    "code": "688065"
  }
]